Centrient Pharmaceuticals joins UNGC
Reinforcing commitment to ethical and sustainable growth
Reinforcing commitment to ethical and sustainable growth
AINU is set to accelerate its expansion footprint, enhance operational capabilities
Ranibizumab is a recombinant humanized IgG1 monoclonal antibody fragment that binds to and inhibits vascular endothelial growth factor A
Hikal has reported total income of Rs. 381.4 crores during the period ended June 30, 2025
With this addition, the company’s total Installed MCC Capacity will rise to 30,000 MTPA
Currently focused on platform-related queries, elva.AI is the first step in ekincare’s broader roadmap
The Q-Switched Nd:YAG system is suitable for all skin types and offers versatility in treating dermal and epidermal pigmentation
Revenue from operations rose 14.8 per cent year-on-year to Rs. 3,942 crore
Athena is also exploring the use of this technology for expanded carrier screening
Subscribe To Our Newsletter & Stay Updated